tiprankstipranks
Ziopharm Oncology (ZIOP)
NASDAQ:ZIOP
US Market

Ziopharm Oncology (ZIOP) Stock Investors

0 Followers
Based on 553,377 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ZIOP
On average, investors allocate 3.39% of their portfolios to ZIOP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ZIOP

2.7%
Last 7
Days
22.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ZIOP, out of 553,377 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ZIOP Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$1.64
Based on the activity of 45,532 investors who made their portfolios public
The table shows changes in ZIOP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ZIOP Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
10.23%
-0.85%
-5.10%
60.26B
Healthcare
Sorrento Therapeutics
5.84%
-0.42%
-7.82%
882.25M
Healthcare
Aquestive Therapeutics
6.79%
-0.90%
-4.92%
108.44M
Healthcare
Micron
7.29%
-0.49%
-6.05%
88.15B
Technology
Alector
3.65%
+2.75%
+0.06%
1.15B
Healthcare
Ionis Pharmaceuticals
3.08%
-1.86%
-3.98%
4.44B
Healthcare
Epizyme
1.58%
+0.21%
-1.90%
112.46M
Healthcare
Sangamo Biosciences
1.61%
+0.21%
-2.69%
804.12M
Healthcare
ImmunoGen
3.32%
+1.12%
-9.70%
1.12B
Healthcare
Rigel
2.72%
+0.21%
-10.40%
395.02M
Healthcare
Based on the activity of 553,377 active portfolios
Open your Smart Portfolio

ZIOP Investor Analysis

ZIOP investors under 35

Under 35

6.6%
Last 30 days
Holdings Change
8.3%
of ZIOP holders
are under 35
Average Segment Performance
Average P/E Ratio-
Beta1.13
Dividend Yield13.17%
ZIOP investors between 35–55

Between 35–55

25.8%
Last 30 days
Holdings Change
66.7%
of ZIOP holders
are between 35–55
Average Segment Performance
Average P/E Ratio-
Beta1.13
Dividend Yield16.25%
ZIOP investors over 55

Over 55

56.9%
Last 30 days
Holdings Change
25.0%
of ZIOP holders
are over 55
Average Segment Performance
Average P/E Ratio-
Beta1.22
Dividend Yield18.48%
Overview of age group and performance of ZIOP stock investors
See who invests in ZIOP according to age group and performance.

FAQ

How many retail Investors hold ZIOP?
<0.1% of TipRanks' retail investors hold ZIOP in their portfolios.
    What is ZIOP Investor Sentiment?
    ZIOP’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ZIOP in the last 7 days?
      ▲ 2.7% of TipRanks' retail investors changed their holding of ZIOP in the last 7 days.
        What percentage of retail investors changed their holding of ZIOP in the last 30 days?
        ▼ 22.6% of TipRanks' retail investors changed their holding of ZIOP in the last 30 days.
          What is the average age of retail investors who hold ZIOP?
          The average age of ZIOP Holders is between 35–55.
            What other stocks have ZIOP investors also bought?
            ZIOP Investors also bought MRNA, SRNE, AQST, MU, ALEC, IONS, EPZM, SGMO, IMGN, RIGL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              DRDRMCI Onehealth Technologies, Inc. Class A
              AIONAion Therapeutic Inc
              NEONNeonMind Biosciences Inc
              HAVLFHAVN Life Sciences
              MSETMindset Pharma Inc.
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis